BR9610207A - Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos - Google Patents

Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos

Info

Publication number
BR9610207A
BR9610207A BR9610207A BR9610207A BR9610207A BR 9610207 A BR9610207 A BR 9610207A BR 9610207 A BR9610207 A BR 9610207A BR 9610207 A BR9610207 A BR 9610207A BR 9610207 A BR9610207 A BR 9610207A
Authority
BR
Brazil
Prior art keywords
reductase inhibitors
aldose reductase
acetic acids
phenoxy acetic
hyperglycemic agents
Prior art date
Application number
BR9610207A
Other languages
English (en)
Inventor
Iwan Gunawan
Michael Sotiorios Malamas
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9610207A publication Critical patent/BR9610207A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • C07C69/712Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/74Unsaturated compounds containing —CHO groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9610207A 1995-08-28 1996-08-01 Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos BR9610207A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US285595P 1995-08-28 1995-08-28
PCT/US1996/012550 WO1997008126A1 (en) 1995-08-28 1996-08-01 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents

Publications (1)

Publication Number Publication Date
BR9610207A true BR9610207A (pt) 1999-02-02

Family

ID=21702866

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610207A BR9610207A (pt) 1995-08-28 1996-08-01 Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos

Country Status (9)

Country Link
US (1) US5677342A (pt)
EP (1) EP0847379A1 (pt)
JP (1) JPH11512095A (pt)
CN (1) CN1200106A (pt)
AU (1) AU701068B2 (pt)
BR (1) BR9610207A (pt)
CA (1) CA2227691A1 (pt)
NZ (1) NZ313896A (pt)
WO (1) WO1997008126A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
CA2330555A1 (en) * 1998-05-12 1999-11-18 Jay Edward Wrobel Naphtho[2,3-b]heteroar-4-yl derivatives
WO2002024633A1 (en) * 2000-09-21 2002-03-28 Sankyo Company, Limited Phenylpropionic acid derivatives
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
ATE517085T1 (de) 2004-11-23 2011-08-15 Astrazeneca Ab Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate
WO2007039736A1 (en) 2005-10-06 2007-04-12 Astrazeneca Ab Novel compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
PL2593456T3 (pl) 2010-07-16 2017-06-30 The Trustees Of Columbia University In The City Of New York Inhibitory reduktazy aldozowej i ich zastosowania
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
IL283809B2 (en) 2016-06-21 2024-01-01 Univ Columbia Compounds for use in a method of treating neuropathy, retinopathy, nephropathy, or cardiomyopathy
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
AU2020254610A1 (en) 2019-04-01 2021-11-18 Applied Therapeutics Inc. Inhibitors of aldose reductase
CN113966396A (zh) 2019-05-07 2022-01-21 迈阿密大学 遗传性神经病和相关障碍的治疗和检测
CN115996725A (zh) 2020-05-01 2023-04-21 应用治疗公司 用于治疗山梨糖醇脱氢酶缺乏症的醛糖还原酶抑制剂
CN112574136A (zh) * 2020-12-08 2021-03-30 北京理工大学 一系列苯并噁唑酮类衍生物的结构、制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76950B (pt) * 1980-12-18 1984-09-04 Wellcome Found
US4500544A (en) * 1981-09-10 1985-02-19 Chugai Seiyaku Kabushiki Kaisha Ascochlorin derivatives, and pharmaceutical composition containing the same
JP2558473B2 (ja) * 1987-08-24 1996-11-27 大日本製薬株式会社 チアゾリジン誘導体
US4897405A (en) * 1989-04-21 1990-01-30 American Home Products Corporation Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
JP2873599B2 (ja) * 1990-03-09 1999-03-24 寿製薬株式会社 新規ベンゾフラン誘導体、尿酸排泄剤及びその製法
US5183825A (en) * 1992-04-07 1993-02-02 American Home Products Corporation 4-arylmethyl-5-alkyl-3H-pyrazol-3-ones and hypoglycemic use
US5324743A (en) * 1992-12-10 1994-06-28 Eli Lilly And Company Leukotriene B4 antagonists
US5399588A (en) * 1993-12-14 1995-03-21 American Home Products Corporation Naphthalenylmethyl cycloalkenone acetic acids and analogs thereof useful as aldose reductase inhibitors

Also Published As

Publication number Publication date
CN1200106A (zh) 1998-11-25
US5677342A (en) 1997-10-14
CA2227691A1 (en) 1997-03-06
NZ313896A (en) 2000-08-25
EP0847379A1 (en) 1998-06-17
WO1997008126A1 (en) 1997-03-06
JPH11512095A (ja) 1999-10-19
AU6643896A (en) 1997-03-19
AU701068B2 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
DE69813570D1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
FI972062A7 (fi) Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina
FI965019A7 (fi) Entsyymi-inhibiittoreita
EE03765B1 (et) Propioonhappe derivaadid ja nende kasutamine
NO973283D0 (no) Konjugater mellom terapeutiske forbindelser og fettsyrer
FI945688A7 (fi) Etikkahappojohdannaisia
FI974088L (fi) Linearisointimenetelmä ja vahvistinjärjestely
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
FI951773A0 (fi) Alfa-animoalkaanihapot ja niiden pelkistymistuotteet
DE69602755D1 (de) Elektromagnetisches lager
NO20016272D0 (no) Substituerte fenoksyeddiksyrer
BR9608239A (pt) Inibidroes de sialidase bacterial e processos de fabricação e uso dos mesmos
ATE210112T1 (de) Substituierte 4-biphenyl-4- hydroxybuttersäurederivate als matrix metallprotease inhibitoren
FI951101L (fi) 5-vinyyli- ja 5-etinyylikinoloni- ja -naftyridonikarboksyylihapot
BR9510062A (pt) Macromonômeto esterificado e composição
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
DE69627043T2 (de) Klasse-d-verstärker
FI970195L (fi) Trifluormetyylikinoliinikarboksyylihappojohdannainen
DE69826919D1 (de) Niederspannungshochfrequenzverstärker
FI954680A7 (fi) Kinoloni- ja naftyridonikarboksyylihappojohdannaiset
BR9610139A (pt) Derivado de ácido carboxílico
EP0942231A4 (en) DEVICE AND METHOD FOR DESODORATION
FR2756436B1 (fr) Amplificateur transconducteur
DE59404674D1 (de) Hydraulischer Verstärker
BR9609644A (pt) Novo quiloxaina e ácidos quinoxalinailalcano-fosfônico

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law